Finally, in clinical practice, some medications used to treat addiction can also affect appetite and body weight
Early observational data and clinical experience suggest GLP-1s do not typically trigger or exacerbate ulcerative colitis flares, though individual gut microbiome composition and disease severity may influence tolerability and symptom response
Pharmacy availability at the time of approval influences which compounded options can be prepared and dispensed
GLP-1 uptake by country will continue to diverge along these lines for the foreseeable future, shaped by the interplay of healthcare financing, regulatory sequencing, and the pace at which national health systems formally recognise obesity as a chronic disease requiring structured, long-term pharmacological management
diabetic neuropathy-related ED as a supportive therapy
Developing user-friendly formulations that are easy to apply, non-greasy, and aesthetically pleasing can significantly enhance patient adherence to drug treatment regimens [350]